Elcar, 300 mg/ml 50 ml

Elcar is a remedy for the correction of metabolic processes.

L-carnitine (a natural substance related to the B vitamins) is involved in metabolic processes as a carrier of fatty acids through cell membranes from the cytoplasm to the mitochondria where these acids are oxidized (beta-oxidation process) with the formation of large amounts of metabolic energy (in the form of ATP). L-carnitine increases resistance of nervous tissue to damaging factors (hypoxia, injury, intoxication, etc.), inhibits the formation of keto acids and anaerobic glycolysis, reduces lactacidosis.

The drug replenishes alkaline blood reserve, restores autoregulation of cerebral hemodynamics and increases blood supply to the affected area, accelerates reparative processes in the lesion and has an anabolic effect.

Pharmacokinetics

It is well absorbed in the intestine, the concentration in plasma reaches a maximum of 3 hours and remains in therapeutic range for 9 hours. It penetrates easily into the liver and myocardium, slower in the muscles. It is excreted by the kidneys, mainly in the form of acyl esters.

Indications

The drug is used as part of complex therapy.

intense physical activity and psycho-emotional stress: to increase performance, endurance, reduce fatigue, including in older people;
during the period of rehabilitation after illnesses and surgical interventions, injuries, including to accelerate tissue regeneration;
complex therapy of chronic gastritis and chronic pancreatitis with decreased secretory function;
complex therapy of skin diseases (psoriasis, seborrheic eczema, focal scleroderma and discoid lupus erythematosus);
mild hyperthyroidism;
neurological manifestations in vascular, toxic and traumatic brain lesions;
anorexia nervosa syndrome;
diseases accompanied by a lack of carnitine or its increased loss (myopathies, cardiomyopathies, mitochondrial diseases, hereditary diseases with concomitant mitochondrial deficiency) – to compensate for its deficiency as part of complex therapy;
in pediatric practice (treatment of children under 3 years of age under the supervision of a physician): when caring for premature infants, newborns who have suffered birth trauma or asphyxia; children with a sluggish sucking reflex and low weight gain; reduced muscle tone, with insufficient development of motor and mental functions, as well as for the purpose of preventing these disorders in children at risk; with stunted growth and underweight in children and adolescents under 16 years of age.
in adults in sports medicine and during intense training (during the training process when working on aerobic performance): to improve speed-strength indicators and coordination of movements, to increase muscle mass and reduce body fat mass, to prevent post-training syndrome (accelerating recovery processes after physical activity), in case of traumatic injuries in order to accelerate muscle regeneration.

Pharmacological effect

Elkar is a means for correcting metabolic processes.

L-carnitine (a natural substance related to B vitamins) is involved in metabolic processes as a carrier of fatty acids across cell membranes from the cytoplasm to the mitochondria, where these acids are oxidized (beta-oxidation process) to produce large amounts of metabolic energy (in the form of ATP). L-carnitine increases the resistance of nervous tissue to damaging factors (hypoxia, trauma, intoxication, etc.), inhibits the formation of ketoacids and anaerobic glycolysis, and reduces the degree of lactic acidosis.

The drug replenishes the alkaline reserve of the blood, helps restore autoregulation of cerebral hemodynamics and increase blood supply to the affected area, accelerates reparative processes in the lesion and has an anabolic effect.

Pharmacokinetics

Well absorbed in the intestine, plasma concentrations reach a maximum after 3 hours and remain in the therapeutic range for 9 hours. It penetrates easily into the liver and myocardium, and more slowly into the muscles. It is excreted by the kidneys, mainly in the form of acyl esters.

Special instructions

Treatment of children under 3 years of age should be carried out under the supervision of a doctor.

The drug does not affect the performance of potentially hazardous activities that require special attention and quick reactions (driving a car and other vehicles, working with moving mechanisms, working as a dispatcher and operator, etc.)

Active ingredient

Levocarnitine

Composition

1 ml of oral solution contains:

active ingredient:

levocarnitine (carnifit) 300 mg;

excipients:

citric acid monohydrate 1.2 mg,

methyl parahydroxybenzoate 0.5 mg,

propyl parahydroxybenzoate 0.2 mg,

purified water up to 1 ml.

Pregnancy

Due to the lack of research, use during pregnancy and lactation is not recommended.

Contraindications

Individual intolerance to the components of the drug.

Side Effects

Possible allergic reactions, gastralgia, dyspepsia, myasthenia gravis (in patients with uremia).

Interaction

Glucocorticosteroids promote the accumulation of the drug in tissues (except the liver), other anabolic steroids enhance the effect.

Overdose

Symptoms: dyspeptic disorders, myasthenic disorders (in patients with uremia).

Treatment: gastric lavage, taking activated charcoal.

Storage conditions

In a place protected from light, at a temperature not exceeding 25 °C

Shelf life

3 years

Manufacturer

Pik-Pharma, Russia